Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_assertion type Assertion NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_head.
- NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_assertion description "[The results indicate a reduced non-melanoma skin cancer risk in relation to XPD Asp312Asn and Lys751Gln variants; these polymorphisms may modify the association between non-melanoma skin cancer and arsenic exposure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_provenance.
- NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_assertion evidence source_evidence_literature NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_provenance.
- NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_assertion SIO_000772 17687452 NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_provenance.
- NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_assertion wasDerivedFrom lhgdn-20090331 NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_provenance.
- NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_assertion wasGeneratedBy ECO_0000203 NP145624.RAcw1xfaf65qfhPFP2NHoJJ61PZKkwWtKpl2vGUScdZL4130_provenance.